NATUS MEDICAL INC (NTUS) Stock Price, Quote, News and Overview
NASDAQ:NTUS - Nasdaq - US6390501038 - Common Stock - Currency: USD
NTUS Quote, Performance and Key Statistics
32.96
+0.03 (+0.09%)
The current stock price of NTUS is 32.96 USD. In the past month the price increased by 2.07%. In the past year, price increased by 32.69%.
NTUS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About NTUS
Company Profile
Natus Medical, Inc. provides medical device solutions focuses on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. The company is headquartered in Middleton, Wisconsin and currently employs 1,400 full-time employees. The company went IPO on 2001-07-20. The company provides product solutions for three end markets: Neuro, Newborn Care, and Hearing & Balance. Its Neuro includes products and services that provide diagnostic, therapeutic, and surgical solutions in neurodiagnostic, neurocritical care and neurosurgery. Newborn Care includes products and services for newborn care, including hearing screening, brain monitoring, eye imaging, jaundice management, live video streaming and various disposable newborn care supplies. Hearing & Balance includes products for hearing assessment and diagnostics, and hearing aid fitting, including computer-based audiological, otoneurologic and vestibular instrumentation for hearing care professionals. Its Neuro products and services include Electroencephalography, Electromyography, Polysomnography, Subdural electrodes, and Cranial access kits.
Company Info
NATUS MEDICAL INC
3150 Pleasant View Road
Middleton WISCONSIN 94566 US
CEO: Jonathan A. Kennedy
Employees: 1400
Company Website: http://www.natus.com/
Phone: 16088298500.0
NATUS MEDICAL INC / NTUS FAQ
What is the stock price of NATUS MEDICAL INC today?
The current stock price of NTUS is 32.96 USD. The price increased by 0.09% in the last trading session.
What is the ticker symbol for NATUS MEDICAL INC stock?
The exchange symbol of NATUS MEDICAL INC is NTUS and it is listed on the Nasdaq exchange.
On which exchange is NTUS stock listed?
NTUS stock is listed on the Nasdaq exchange.
What is NATUS MEDICAL INC worth?
NATUS MEDICAL INC (NTUS) has a market capitalization of 1.14B USD. This makes NTUS a Small Cap stock.
How many employees does NATUS MEDICAL INC have?
NATUS MEDICAL INC (NTUS) currently has 1400 employees.
What are the support and resistance levels for NATUS MEDICAL INC (NTUS) stock?
NATUS MEDICAL INC (NTUS) has a support level at 32.8 and a resistance level at 33.11. Check the full technical report for a detailed analysis of NTUS support and resistance levels.
Is NATUS MEDICAL INC (NTUS) expected to grow?
The Revenue of NATUS MEDICAL INC (NTUS) is expected to grow by 5.1% in the next year. Check the estimates tab for more information on the NTUS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NATUS MEDICAL INC (NTUS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NTUS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NTUS, evaluating the profitability, health, valuation and growth aspects
- NATUS MEDICAL INC (NTUS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NATUS MEDICAL INC (NTUS) Sales and EPS estimates to see what analysts future expectations are.
- NATUS MEDICAL INC (NTUS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NATUS MEDICAL INC (NTUS) Insider and Institutional Ownership to learn about the owners and their transactions.
- NATUS MEDICAL INC (NTUS) Stock Chart to make your own analysis
- NATUS MEDICAL INC (NTUS) Latest news and press-releases to stay up to date.
Does NATUS MEDICAL INC (NTUS) stock pay dividends?
NTUS does not pay a dividend.
When does NATUS MEDICAL INC (NTUS) report earnings?
NATUS MEDICAL INC (NTUS) will report earnings on 2022-08-04, after the market close.
What is the Price/Earnings (PE) ratio of NATUS MEDICAL INC (NTUS)?
The PE ratio for NATUS MEDICAL INC (NTUS) is 26.16. This is based on the reported non-GAAP earnings per share of 1.26 and the current share price of 32.96 USD. Check the full fundamental report for a full analysis of the valuation metrics for NTUS.
NTUS Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to NTUS. When comparing the yearly performance of all stocks, NTUS is one of the better performing stocks in the market, outperforming 93.25% of all stocks.
NTUS Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to NTUS. NTUS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
NTUS Financial Highlights
Over the last trailing twelve months NTUS reported a non-GAAP Earnings per Share(EPS) of 1.26. The EPS increased by 147.06% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.65% | ||
| ROA | 2.23% | ||
| ROE | 2.94% | ||
| Debt/Equity | 0 |
NTUS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to NTUS. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 22.4% and a revenue growth 5.1% for NTUS